Hematology

                   

Patients and Staff Move Out of Princess Royal Hospital and into New Cancer Centre ; A New...

redorbit.com     26-Aug-2008          

A new pounds70m cancer centre has opened for patients at Castle Hill Hospital in Cottingham. The opening of the pounds70m oncology and haematology centre came after patients and staff relocated from the Princess Royal...                    

comments

Cerebral Infarction: Data on cerebral infarction detailed by researchers at Institute of...

newsrx.com     26-Aug-2008          

Current study results from the report, 'Potential biomarkers of acute cerebral infarction detected by SELDI-TOF-MS,' have been published. According to recent research from Wuhan, People's Republic of China, "No single...                    

comments

REPORT FOR SECOND QUARTER AND FIRST-HALF YEAR 2008

euroinvestor.co.uk     22-Aug-2008          

Clinical development of ELACYT in haematology expanded Oslo, Norway, 22 August 2008: Clavis Pharma presents today results for the second quarter and first half-year 2008, and reports an expansion of the ELACYT(TM) clinical...                    

comments

Vion Pharma tries another Phase 3 trial of blood cancer drug

pharmiweb.co.uk     20-Aug-2008   6 related          

will begin a Phase 3 clinical trial this fall, in collaboration with the Dutch-Belgian Cooperative Trial Group for Hematology Oncology (HOVON), to test its anti-blood cancer agent, Cloretazine. The drug is intended to treat...                    

comments

                   

Vion Pharmaceuticals Enters Into Agreement With HOVON To Conduct A Phase III Clinical Trial Of...

medicalnewstoday.com     20-Aug-2008          

VION PHARMACEUTICALS, INC. (Pink Sheets: VION) announced that it had entered into an agreement with the Dutch-Belgian Cooperative Trial Group for Hematology Oncology (the "HOVON") to conduct a clinical trial of laromustine...                    

comments

Focus on the Worldwide Diagnostics Market Research Bundle (Worldwide Market for In Vitro...

tmcnet.com     19-Aug-2008   2 related          

LONDON, UNITED KINGDOM, August 19 / MARKET WIRE/ -- Worldwide Diagnostics Market Research Bundle (Worldwide Market for In Vitro Diagnostic Tests 6th Ed., SNP Genotyping and Analysis Markets, Companion Diagnostics Markets)...                    

comments

                   

How Common is RhD Isoimmunization?

pediatriceducation.org     18-Aug-2008          

Patient Presentation A 1-month-old female came to clinic for her follow-up evaluation. She was known to have RhD isoimmunization that had required one blood transfusion and phototherapy for 5 days after birth at 38 weeks...                    

comments

CC-Chemokine ligand 20/macrophage inflammatory protein-3alpha and CC-chemokine receptor 6 are...

biowizard.com     18-Aug-2008          

Hematology and Bone Marrow Transplantation Center, University of Parma, Parma, Italy. Nicola.Giuliani@unipr.it The expression of the chemokine CC-chemokine ligand 20 (CCL20)/macrophage inflammatory protein (MIP)-3alpha and its...                    

comments

7:00 AM (PT) - Trends in Multiparameter Flow Cytometry in Hematology

uwtv.org     17-Aug-2008   1 related          

Flow cytometry is increasingly utilized as primary tool for the diagnosis of hematopoietic neoplasia in a clinical laboratory setting. The use of increased numbers of simultaneous fluorochromes offers the following potential...                    

comments

Indian kids respond poorly to chemotherapy: Study

hindustantimes.com     15-Aug-2008          

Indian children suffering from a common form of leukaemia respond poorly to chemotherapy as compared to their western counterparts, found a study at the All India Institute of Medical Sciences (AIIMS). Dr Renu Saxena and Dr...                    

comments

1 2 3 4 5 next »